MYIA
BIIB icon

Mount Yale Investment Advisors’s Biogen BIIB Stock Holding History

Mount Yale Investment Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$683K Buy
+3,724
New +$686K 0.02% 617
2025
Q3 		– Sell
-200
Closed -$25.1K – 773
2025
Q2 		$25.1K Buy
+200
New +$24.9K ﹤0.01% 996
2023
Q2 		– Sell
-893
Closed -$248K – 487
2023
Q1 		$248K Sell
893
-457
-34% -$126K 0.03% 423
2022
Q4 		$374K Buy
+1,350
New +$381K 0.04% 323
2018
Q4 		– Sell
-248
Closed -$82K – 366
2018
Q3 		$82K Buy
248
+10
+4% +$3.44K 0.01% 500
2018
Q2 		$69K Hold
238
– – 0.01% 569
2018
Q1 		$65K Buy
+238
New +$73.9K 0.01% 566

Other funds holding BIIB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Mount Yale Investment Advisors's BIIB Position: Q1 2026 in Review

Mount Yale Investment Advisors opened a new position in Biogen (BIIB) in Q1 2026: 3,724 shares worth $683K. The stake represents 0.02% of the portfolio and ranks #617 among its holdings. This is a return to the name: Mount Yale Investment Advisors previously reported a position in BIIB as recently as Q2 2025.

Mount Yale Investment Advisors first reported a position in BIIB in Q1 2018 and has held it in 7 quarters since. 1,008 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

  • Mount Yale Investment Advisors held 3,724 shares of Biogen worth $683K as of Q1 2026.
  • Biogen was a new Mount Yale Investment Advisors position in Q1 2026.
  • Biogen made up 0.02% of Mount Yale Investment Advisors's portfolio in Q1 2026, its #617 holding.
  • Mount Yale Investment Advisors first reported a position in Biogen in Q1 2018 and has held it in 7 quarters since.
  • 1,008 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on Mount Yale Investment Advisors's 13F filing for Q1 2026, filed 27 Apr 2026.